JP2005526773A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005526773A5 JP2005526773A5 JP2003575960A JP2003575960A JP2005526773A5 JP 2005526773 A5 JP2005526773 A5 JP 2005526773A5 JP 2003575960 A JP2003575960 A JP 2003575960A JP 2003575960 A JP2003575960 A JP 2003575960A JP 2005526773 A5 JP2005526773 A5 JP 2005526773A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally
- substituted
- optionally substituted
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0206218A GB0206218D0 (en) | 2002-03-15 | 2002-03-15 | Organic compounds |
| GB0229627A GB0229627D0 (en) | 2002-12-19 | 2002-12-19 | Organic compounds |
| PCT/EP2003/002715 WO2003077907A1 (en) | 2002-03-15 | 2003-03-14 | Azetidine derivatives as ccr-3 receptor antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008302924A Division JP2009102325A (ja) | 2002-03-15 | 2008-11-27 | Ｃｃｒ−３レセプターアンタゴニストとしてのアゼチジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005526773A JP2005526773A (ja) | 2005-09-08 |
| JP2005526773A5 true JP2005526773A5 (enExample) | 2009-06-25 |
| JP4332433B2 JP4332433B2 (ja) | 2009-09-16 |
Family
ID=28043401
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003575960A Expired - Fee Related JP4332433B2 (ja) | 2002-03-15 | 2003-03-14 | Ｃｃｒ−３レセプターアンタゴニストとしてのアゼチジン誘導体 |
| JP2008302924A Pending JP2009102325A (ja) | 2002-03-15 | 2008-11-27 | Ｃｃｒ−３レセプターアンタゴニストとしてのアゼチジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008302924A Pending JP2009102325A (ja) | 2002-03-15 | 2008-11-27 | Ｃｃｒ−３レセプターアンタゴニストとしてのアゼチジン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7288537B2 (enExample) |
| EP (1) | EP1487435A1 (enExample) |
| JP (2) | JP4332433B2 (enExample) |
| KR (1) | KR100706270B1 (enExample) |
| CN (1) | CN1638761A (enExample) |
| AR (1) | AR041786A1 (enExample) |
| AU (1) | AU2003227072B2 (enExample) |
| BR (1) | BR0308419A (enExample) |
| CA (1) | CA2479266A1 (enExample) |
| CO (1) | CO5611125A2 (enExample) |
| IL (1) | IL164016A0 (enExample) |
| MX (1) | MXPA04009057A (enExample) |
| NO (1) | NO20044373L (enExample) |
| NZ (1) | NZ535082A (enExample) |
| PL (1) | PL371055A1 (enExample) |
| RU (1) | RU2314292C2 (enExample) |
| TW (2) | TW200305395A (enExample) |
| WO (1) | WO2003077907A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050026844A1 (en) | 2003-04-03 | 2005-02-03 | Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
| US20070021404A1 (en) * | 2003-06-24 | 2007-01-25 | Dan Peters | Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| BRPI0414416A (pt) * | 2003-09-15 | 2006-11-14 | Novartis Ag | derivados de azetidinas 1,3-di-substituìdas para aplicação como antagonistas de receptores ccr-3 no tratamento de doenças inflamatórias e alérgicas |
| GB0402101D0 (en) | 2004-01-30 | 2004-03-03 | Novartis Ag | Organic compounds |
| EP1765311A4 (en) | 2004-03-16 | 2009-04-29 | Univ California | REDUCTION OF NEPHROPATHY WITH INHIBITORS OF SOLUBLE EPOXY HYDROLASE AND EPOXYEICOSANOIDS |
| GB0417801D0 (en) * | 2004-08-10 | 2004-09-15 | Novartis Ag | Organic compounds |
| AU2005295167B2 (en) | 2004-10-20 | 2012-05-10 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| GB0607196D0 (en) * | 2006-04-11 | 2006-05-17 | Prosidion Ltd | G-protein coupled receptor agonists |
| GB0720389D0 (en) * | 2007-10-18 | 2008-11-12 | Prosidion Ltd | G-Protein Coupled Receptor Agonists |
| GB0720390D0 (en) * | 2007-10-18 | 2007-11-28 | Prosidion Ltd | G-Protein coupled receptor agonists |
| WO2010129351A1 (en) | 2009-04-28 | 2010-11-11 | Schepens Eye Research Institute | Method to identify and treat age-related macular degeneration |
| PH12013501442B1 (en) | 2011-01-07 | 2018-04-20 | Novartis Ag | Immunosuppressant formulations |
| ES2764840T3 (es) | 2015-01-28 | 2020-06-04 | Univ Bordeaux | Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica |
| SG11202007072RA (en) | 2018-01-26 | 2020-08-28 | Rapt Therapeutics Inc | Chemokine receptor modulators and uses thereof |
| CN110498750B (zh) * | 2019-09-02 | 2021-10-15 | 南通大学 | 一种(r)-4-羟基-1-甲氧基丁-2-基氨基甲酸叔丁酯的合成方法 |
| TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法 |
| US12221463B2 (en) | 2020-08-07 | 2025-02-11 | The Board Of Regents Of The University Of Oklahoma | Method of promoting wound healing by inhibiting CCR3 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2093456B (en) | 1980-10-08 | 1984-12-05 | Robins Co Inc A H | 1-r1-3-phenozyazetidines |
| US5095014A (en) * | 1990-12-07 | 1992-03-10 | A. H. Robins Company, Incorporated | 3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having anticonvulsant activity |
| DE4335718A1 (de) * | 1993-10-20 | 1995-04-27 | Merck Patent Gmbh | Cyclische Aminderivate |
| WO1999004794A1 (en) * | 1997-07-25 | 1999-02-04 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| IL125658A0 (en) * | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| PE20001420A1 (es) * | 1998-12-23 | 2000-12-18 | Pfizer | Moduladores de ccr5 |
| GB0019006D0 (en) * | 2000-08-04 | 2000-09-20 | Astrazeneca Ab | Novel compounds |
| GB0117387D0 (en) * | 2001-07-17 | 2001-09-05 | Novartis Ag | Organic compounds |
-
2003
- 2003-03-13 TW TW092105495A patent/TW200305395A/zh unknown
- 2003-03-13 AR ARP030100876A patent/AR041786A1/es not_active Application Discontinuation
- 2003-03-13 TW TW096115427A patent/TW200800167A/zh unknown
- 2003-03-14 CN CNA038056488A patent/CN1638761A/zh active Pending
- 2003-03-14 MX MXPA04009057A patent/MXPA04009057A/es active IP Right Grant
- 2003-03-14 NZ NZ535082A patent/NZ535082A/en unknown
- 2003-03-14 EP EP03744367A patent/EP1487435A1/en not_active Withdrawn
- 2003-03-14 PL PL03371055A patent/PL371055A1/xx not_active Application Discontinuation
- 2003-03-14 BR BR0308419-1A patent/BR0308419A/pt not_active IP Right Cessation
- 2003-03-14 KR KR1020047013800A patent/KR100706270B1/ko not_active Expired - Fee Related
- 2003-03-14 WO PCT/EP2003/002715 patent/WO2003077907A1/en not_active Ceased
- 2003-03-14 JP JP2003575960A patent/JP4332433B2/ja not_active Expired - Fee Related
- 2003-03-14 US US10/507,139 patent/US7288537B2/en not_active Expired - Fee Related
- 2003-03-14 AU AU2003227072A patent/AU2003227072B2/en not_active Ceased
- 2003-03-14 RU RU2004130487/04A patent/RU2314292C2/ru not_active IP Right Cessation
- 2003-03-14 CA CA002479266A patent/CA2479266A1/en not_active Abandoned
- 2003-03-14 IL IL16401603A patent/IL164016A0/xx unknown
-
2004
- 2004-09-14 CO CO04091228A patent/CO5611125A2/es not_active Application Discontinuation
- 2004-10-14 NO NO20044373A patent/NO20044373L/no not_active Application Discontinuation
-
2008
- 2008-11-27 JP JP2008302924A patent/JP2009102325A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005526773A5 (enExample) | ||
| RU2503679C2 (ru) | Ингибиторы репликации вируса иммунодефицита человека | |
| JP2006524660A5 (enExample) | ||
| JP2005523922A5 (enExample) | ||
| JP2015501833A5 (enExample) | ||
| RU2350605C2 (ru) | Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ | |
| JP2005539088A5 (enExample) | ||
| JP2013531029A5 (enExample) | ||
| JP2015504067A5 (enExample) | ||
| JP2017537949A5 (enExample) | ||
| JP2014521688A5 (enExample) | ||
| JP2006505543A5 (enExample) | ||
| JP2010524932A5 (enExample) | ||
| JP2011527334A5 (enExample) | ||
| AR035371A1 (es) | Aminotiazoles, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de un medicamento | |
| JP2012505871A5 (enExample) | ||
| JP2001526269A5 (enExample) | ||
| JP2013531031A5 (enExample) | ||
| RU2010126056A (ru) | Органические соединения | |
| JP2011509309A5 (enExample) | ||
| JP2010527913A5 (enExample) | ||
| JP2009518365A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| JP2013544860A5 (enExample) | ||
| JP2019513745A5 (enExample) |